Forest Pays Up To $10M In MDL Over Celexa, Lexapro

By Beth Winegarner (March 14, 2014, 6:33 PM EDT) -- Forest Laboratories Inc. agreed to pay between $7.7 million and $10.4 million to settle multidistrict litigation accusing the drugmaker of misleading Missouri parents into buying Celexa and Lexapro for children although the drugs were only approved for adults, according to papers filed in Massachusetts federal court Thursday.

The plaintiffs urged U.S. District Court Judge Nathaniel M. Gorton to certify a settling class of parents in Missouri and appoint Pendley Baudin & Coffin LLP and Baum Hedlund Aristei & Goldman PC as the settlement counsel. They also asked the court to name plaintiffs Ruth Dunham and Tanya Shippy as representatives for the class....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!